These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Systematic Review Article: New Drug Strategies for Treating Resistant Hypertension-the Importance of a Mechanistic, Personalized Approach. Nardoianni G; Pala B; Scoccia A; Volpe M; Barbato E; Tocci G High Blood Press Cardiovasc Prev; 2024 Mar; 31(2):99-112. PubMed ID: 38616212 [TBL] [Abstract][Full Text] [Related]
5. Resistant hypertension: Renal denervation or intensified medical treatment? Morganti A; Mancia G Eur J Intern Med; 2018 Apr; 50():6-11. PubMed ID: 29287767 [TBL] [Abstract][Full Text] [Related]
6. Hypertension in chronic kidney disease-treatment standard 2023. Georgianos PI; Agarwal R Nephrol Dial Transplant; 2023 Nov; 38(12):2694-2703. PubMed ID: 37355779 [TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study. Rosa J; Widimský P; Toušek P; Petrák O; Čurila K; Waldauf P; Bednář F; Zelinka T; Holaj R; Štrauch B; Šomlóová Z; Táborský M; Václavík J; Kociánová E; Branny M; Nykl I; Jiravský O; Widimský J Hypertension; 2015 Feb; 65(2):407-13. PubMed ID: 25421981 [TBL] [Abstract][Full Text] [Related]
8. Baxdrostat: A Novel Aldosterone Synthase Inhibitor for Treatment Resistant Hypertension. Dogra S; Shah S; Gitzel L; Pusukur B; Sood A; Vyas AV; Gupta R Curr Probl Cardiol; 2023 Nov; 48(11):101918. PubMed ID: 37399857 [TBL] [Abstract][Full Text] [Related]
9. New approaches in the treatment of hypertension. Oparil S; Schmieder RE Circ Res; 2015 Mar; 116(6):1074-95. PubMed ID: 25767291 [TBL] [Abstract][Full Text] [Related]
10. Dual Endothelin Antagonism with Aprocitentan as a Novel Therapeutic Approach for Resistant Hypertension. Heidari Nejad S; Azzam O; Schlaich MP Curr Hypertens Rep; 2023 Oct; 25(10):343-352. PubMed ID: 37566184 [TBL] [Abstract][Full Text] [Related]
11. Eplerenone Versus Spironolactone in Resistant Hypertension: an Efficacy and/or Cost or Just a Men's Issue? Manolis AA; Manolis TA; Melita H; Manolis AS Curr Hypertens Rep; 2019 Mar; 21(3):22. PubMed ID: 30826898 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in understanding and managing resistant/refractory hypertension. Doumas M; Imprialos KP; Kallistratos MS; Manolis AJ F1000Res; 2020; 9():. PubMed ID: 32201574 [TBL] [Abstract][Full Text] [Related]